TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES

GUNTHER M, HAUBECK HD, VANDELEUR E, BLASER J, BENDER S, GUTGEMANN I, FISCHER DC, Tschesche H, GREILING H, HEINRICH PC, GRAEVE L (1994)
ARTHRITIS AND RHEUMATISM 37(3): 395-405.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
GUNTHER, M; HAUBECK, HD; VANDELEUR, E; BLASER, J; BENDER, S; GUTGEMANN, I; FISCHER, DC; Tschesche, HaraldUniBi; GREILING, H; HEINRICH, PC; GRAEVE, L
Abstract / Bemerkung
Objective. To investigate the role of interleukin-6 (IL-6) and transforming growth factor beta 1 (TGF beta 1) in the regulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) synthesis in human articular chondrocytes. Methods. Articular cartilage was obtained from human knee joints 24 hours after death. Chondrocytes were isolated by collagenase digestion and embedded in low-gelling-temperature agarose. After stimulation by cytokines, total RNA was isolated and analyzed by Northern blotting. TIMP-1 protein levels were determined using a competitive enzyme-linked immunosorbent assay. Results. Human chondrocytes in agarose culture expressed messenger RNA (mRNA) for the IL-6 receptor (gp80) and its signal-transducing subunit gp130. In contrast to the findings in a previous study, IL-6 did not stimulate TIMP-1 expression in these cells, whereas TGF beta 1 was an important inducer of TIMP-1 mRNA and protein synthesis. Conclusion. Our findings suggest that TGF beta 1 has a protective effect on the extracellular matrix of human articular chondrocytes.
Erscheinungsjahr
1994
Zeitschriftentitel
ARTHRITIS AND RHEUMATISM
Band
37
Ausgabe
3
Seite(n)
395-405
ISSN
0004-3591
eISSN
1529-0131
Page URI
https://pub.uni-bielefeld.de/record/1629460

Zitieren

GUNTHER M, HAUBECK HD, VANDELEUR E, et al. TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES. ARTHRITIS AND RHEUMATISM. 1994;37(3):395-405.
GUNTHER, M., HAUBECK, H. D., VANDELEUR, E., BLASER, J., BENDER, S., GUTGEMANN, I., FISCHER, D. C., et al. (1994). TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES. ARTHRITIS AND RHEUMATISM, 37(3), 395-405. https://doi.org/10.1002/art.1780370314
GUNTHER, M, HAUBECK, HD, VANDELEUR, E, BLASER, J, BENDER, S, GUTGEMANN, I, FISCHER, DC, et al. 1994. “TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES”. ARTHRITIS AND RHEUMATISM 37 (3): 395-405.
GUNTHER, M., HAUBECK, H. D., VANDELEUR, E., BLASER, J., BENDER, S., GUTGEMANN, I., FISCHER, D. C., Tschesche, H., GREILING, H., HEINRICH, P. C., et al. (1994). TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES. ARTHRITIS AND RHEUMATISM 37, 395-405.
GUNTHER, M., et al., 1994. TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES. ARTHRITIS AND RHEUMATISM, 37(3), p 395-405.
M. GUNTHER, et al., “TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES”, ARTHRITIS AND RHEUMATISM, vol. 37, 1994, pp. 395-405.
GUNTHER, M., HAUBECK, H.D., VANDELEUR, E., BLASER, J., BENDER, S., GUTGEMANN, I., FISCHER, D.C., Tschesche, H., GREILING, H., HEINRICH, P.C., GRAEVE, L.: TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES. ARTHRITIS AND RHEUMATISM. 37, 395-405 (1994).
GUNTHER, M, HAUBECK, HD, VANDELEUR, E, BLASER, J, BENDER, S, GUTGEMANN, I, FISCHER, DC, Tschesche, Harald, GREILING, H, HEINRICH, PC, and GRAEVE, L. “TRANSFORMING GROWTH-FACTOR-BETA-1 REGULATES TISSUE INHIBITOR OF METALLOPROTEINASES-1 EXPRESSION IN DIFFERENTIATED HUMAN ARTICULAR CHONDROCYTES”. ARTHRITIS AND RHEUMATISM 37.3 (1994): 395-405.

57 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Effects of hypoxia on anabolic and catabolic gene expression and DNA methylation in OA chondrocytes.
Alvarez K, de Andrés MC, Takahashi A, Oreffo RO., BMC Musculoskelet Disord 15(), 2014
PMID: 25510649
rAAV-mediated overexpression of TGF-β stably restructures human osteoarthritic articular cartilage in situ.
Venkatesan JK, Rey-Rico A, Schmitt G, Wezel A, Madry H, Cucchiarini M., J Transl Med 11(), 2013
PMID: 24034904
Impact of sex hormones, insulin, growth factors and peptides on cartilage health and disease.
Claassen H, Schicht M, Paulsen F., Prog Histochem Cytochem 45(4), 2011
PMID: 21251699
Effects of hydrostatic pressure on leporine meniscus cell-seeded PLLA scaffolds.
Gunja NJ, Athanasiou KA., J Biomed Mater Res A 92(3), 2010
PMID: 19283825
Changes of human menisci in osteoarthritic knee joints.
Katsuragawa Y, Saitoh K, Tanaka N, Wake M, Ikeda Y, Furukawa H, Tohma S, Sawabe M, Ishiyama M, Yagishita S, Suzuki R, Mitomi H, Fukui N., Osteoarthritis Cartilage 18(9), 2010
PMID: 20633672
Effects of TGF-beta1 and hydrostatic pressure on meniscus cell-seeded scaffolds.
Gunja NJ, Uthamanthil RK, Athanasiou KA., Biomaterials 30(4), 2009
PMID: 18980779
Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes.
Poleni PE, Bianchi A, Etienne S, Koufany M, Sebillaud S, Netter P, Terlain B, Jouzeau JY., Osteoarthritis Cartilage 15(5), 2007
PMID: 17140817
Biological roles of carboxymethyl-chitin associated for the growth factor production.
Kariya H, Kiyohara A, Masuda S, Yoshihara Y, Ueno M, Hashimoto M, Suda Y., J Biomed Mater Res A 83(1), 2007
PMID: 17377966
Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB.
Alexander S, Watt F, Watt F, Sawaji Y, Hermansson M, Saklatvala J., Arthritis Rheum 56(11), 2007
PMID: 17968943
TGF-beta1 immobilized tri-co-polymer for articular cartilage tissue engineering.
Chou CH, Cheng WT, Lin CC, Chang CH, Tsai CC, Lin FH., J Biomed Mater Res B Appl Biomater 77(2), 2006
PMID: 16470812
Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
Wang JJ, Zhang SX, Mott R, Knapp RR, Cao W, Lau K, Ma JX., Diabetes 55(6), 2006
PMID: 16731830
Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction.
Sobajima S, Shimer AL, Chadderdon RC, Kompel JF, Kim JS, Gilbertson LG, Kang JD., Spine J 5(1), 2005
PMID: 15653081
The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2.
Di Sario A, Bendia E, Macarri G, Candelaresi C, Taffetani S, Marzioni M, Omenetti A, De Minicis S, Trozzi L, Benedetti A., Dig Liver Dis 36(11), 2004
PMID: 15571005
Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis.
Hegemann N, Wondimu A, Ullrich K, Schmidt MF., Vet Immunol Immunopathol 91(3-4), 2003
PMID: 12586482
The effects of TIMP-1 and -2 on canine chondrocytes cultured in three-dimensional agarose culture system.
Kuroki K, Cook JL, Kreeger JM, Tomlinson JL., Osteoarthritis Cartilage 11(9), 2003
PMID: 12954233
Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts.
Papakonstantinou E, Aletras AJ, Roth M, Tamm M, Karakiulakis G., Cytokine 24(1-2), 2003
PMID: 14561488
The pathophysiology of osteoarthritis.
Iannone F, Lapadula G., Aging Clin Exp Res 15(5), 2003
PMID: 14703002
Developing strategies for liver fibrosis treatment.
Murphy F, Arthur M, Iredale J., Expert Opin Investig Drugs 11(11), 2002
PMID: 12437504
Small intestinal submucosa versus salt-extracted polyglycolic acid-poly-L-lactic acid: a comparison of neocartilage formed in two scaffold materials.
Beatty MW, Ojha AK, Cook JL, Alberts LR, Mahanna GK, Iwasaki LR, Nickel JC., Tissue Eng 8(6), 2002
PMID: 12542941
Modulation of bovine articular chondrocyte gene expression in vitro by oxygen tension.
Grimshaw MJ, Mason RM., Osteoarthritis Cartilage 9(4), 2001
PMID: 11399100
Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1.
Jia JD, Bauer M, Cho JJ, Ruehl M, Milani S, Boigk G, Riecken EO, Schuppan D., J Hepatol 35(3), 2001
PMID: 11592601
Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis.
Shlopov BV, Gumanovskaya ML, Hasty KA., Arthritis Rheum 43(1), 2000
PMID: 10643716
Transforming growth factor beta superfamily members: role in cartilage modeling.
Frenkel SR, Saadeh PB, Mehrara BJ, Chin GS, Steinbrech DS, Brent B, Gittes GK, Longaker MT., Plast Reconstr Surg 105(3), 2000
PMID: 10724258
Age-related effects of TGF-beta on proteoglycan synthesis in equine articular cartilage.
Iqbal J, Dudhia J, Bird JL, Bayliss MT., Biochem Biophys Res Commun 274(2), 2000
PMID: 10913361
Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines.
Borzì RM, Mazzetti I, Cattini L, Uguccioni M, Baggiolini M, Facchini A., Arthritis Rheum 43(8), 2000
PMID: 10943863
Induction of alpha1-antitrypsin synthesis in human articular chondrocytes by interleukin-6-type cytokines: evidence for a local acute-phase response in the joint.
Fischer DC, Siebertz B, van de Leur E, Schiwy-Bochat KH, Graeve L, Heinrich PC, Haubeck HD., Arthritis Rheum 42(9), 1999
PMID: 10513810
Gene therapy for rheumatoid arthritis. Theoretical considerations.
Chernajovsky Y, Annenkov A, Herman C, Triantaphyllopoulos K, Gould D, Dreja H, Moyes SP, Croxford JL, Mageed RA, Podhajcer OL, Baker D., Drugs Aging 12(1), 1998
PMID: 9467685
Hydrostatic pressure induces expression of interleukin 6 and tumour necrosis factor alpha mRNAs in a chondrocyte-like cell line.
Takahashi K, Kubo T, Arai Y, Kitajima I, Takigawa M, Imanishi J, Hirasawa Y., Ann Rheum Dis 57(4), 1998
PMID: 9709180
Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.
Szekanecz Z, Koch AE, Kunkel SL, Strieter RM., Drugs Aging 12(5), 1998
PMID: 9606615
The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF, Spaull JR, Goldring MB, Koshy PJ, Rowan AD, Shingleton WD., Arthritis Rheum 41(10), 1998
PMID: 9778217
The effects of IL-1 on mitogen-activated protein kinases in rabbit articular chondrocytes.
Scherle PA, Pratta MA, Feeser WS, Tancula EJ, Arner EC., Biochem Biophys Res Commun 230(3), 1997
PMID: 9015364
Hydrostatic pressure influences mRNA expression of transforming growth factor-beta 1 and heat shock protein 70 in chondrocyte-like cell line.
Takahashi K, Kubo T, Kobayashi K, Imanishi J, Takigawa M, Arai Y, Hirasawa Y., J Orthop Res 15(1), 1997
PMID: 9066540
Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Blaser J, Triebel S, Maasjosthusmann U, Romisch J, Krahl-Mateblowski U, Freudenberg W, Fricke R, Tschesche H., Clin Chim Acta 244(1), 1996
PMID: 8919199
Stimulation of TIMP-1 production by oncostatin M in human articular cartilage.
Nemoto O, Yamada H, Mukaida M, Shimmei M., Arthritis Rheum 39(4), 1996
PMID: 8630103
Oncostatin M differentially regulates tissue inhibitors of metalloproteinases TIMP-1 and TIMP-3 gene expression in human synovial lining cells.
Gatsios P, Haubeck HD, Van de Leur E, Frisch W, Apte SS, Greiling H, Heinrich PC, Graeve L., Eur J Biochem 241(1), 1996
PMID: 8898888
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
Duffy MJ, Blaser J, Duggan C, McDermott E, O'Higgins N, Fennelly JJ, Tschesche H., Br J Cancer 71(5), 1995
PMID: 7734294
Normal cartilage structure, biochemistry, and metabolism: a review of the literature.
Dijkgraaf LC, de Bont LG, Boering G, Liem RS., J Oral Maxillofac Surg 53(8), 1995
PMID: 7629621
Evidence for the tissue inhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes.
Triebel S, Bläser J, Gote T, Pelz G, Schüren E, Schmitt M, Tschesche H., Eur J Biochem 231(3), 1995
PMID: 7649172

58 References

Daten bereitgestellt von Europe PubMed Central.

Matrix regulation of cell shape and gene expression.
McDonald JA., Curr. Opin. Cell Biol. 1(5), 1989
PMID: 2697301
Cellular responses to extracellular matrix.
von der Mark K, von der Mark H, Goodman S., Kidney Int. 41(3), 1992
PMID: 1573840
Proteinases and extracellular matrix remodeling.
Alexander CM, Werb Z., Curr. Opin. Cell Biol. 1(5), 1989
PMID: 2697298
The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases.
Docherty AJ, O'Connell J, Crabbe T, Angal S, Murphy G., Trends Biotechnol. 10(6), 1992
PMID: 1368394

Poole, Rheumatology 10(), 1986
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.
Liotta LA, Steeg PS, Stetler-Stevenson WG., Cell 64(2), 1991
PMID: 1703045

Bissel, 1992
Interleukin 1 stimulation of collagenase production by cultured fibroblasts.
Postlethwaite AE, Lachman LB, Mainardi CL, Kang AH., J. Exp. Med. 157(2), 1983
PMID: 6296266
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.
Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK., EMBO J. 6(7), 1987
PMID: 2820711
Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). Up-regulation by interleukin-6 and transforming growth factor beta 1.
Kordula T, Guttgemann I, Rose-John S, Roeb E, Osthues A, Tschesche H, Koj A, Heinrich PC, Graeve L., FEBS Lett. 313(2), 1992
PMID: 1330702
Interleukin-1 beta induces synthesis and secretion of interleukin-6 in human chondrocytes.
Bender S, Haubeck HD, Van de Leur E, Dufhues G, Schiel X, Lauwerijns J, Greiling H, Heinrich PC., FEBS Lett. 263(2), 1990
PMID: 2335234
Independent induction of interleukin 6 and prostaglandin E2 by interleukin 1 in human articular chondrocytes.
Bunning RA, Russell RG, Van Damme J., Biochem. Biophys. Res. Commun. 166(3), 1990
PMID: 2407240
TGF-beta: regulation of extracellular matrix.
Roberts AB, McCune BK, Sporn MB., Kidney Int. 41(3), 1992
PMID: 1573828
Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase.
Bergmann U, Michaelis J, Oberhoff R, Knauper V, Beckmann R, Tschesche H., J. Clin. Chem. Clin. Biochem. 27(6), 1989
PMID: 2547014
Production of hybridoma growth factor by human monocytes.
Aarden LA, De Groot ER, Schaap OL, Lansdorp PM., Eur. J. Immunol. 17(10), 1987
PMID: 3500054
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ., Biochemistry 18(24), 1979
PMID: 518835
Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.
Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T., Science 241(4867), 1988
PMID: 3136546
Molecular cloning and expression of an IL-6 signal transducer, gp130.
Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T., Cell 63(6), 1990
PMID: 2261637

Von, Rheumatology 10(), 1986
IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources.
Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivelis M, Steinman RM, Sehgal PB, May LT., J. Immunol. 143(7), 1989
PMID: 2789256
Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.
Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M., J. Clin. Invest. 83(2), 1989
PMID: 2464001
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis.
Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M., Eur. J. Immunol. 18(11), 1988
PMID: 2462501
Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.
Houssiau FA, Devogelaer JP, Van Damme J, de Deuxchaisnes CN, Van Snick J., Arthritis Rheum. 31(6), 1988
PMID: 3260102
Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells.
Horii Y, Muraguchi A, Suematsu S, Matsuda T, Yoshizaki K, Hirano T, Kishimoto T., J. Immunol. 141(5), 1988
PMID: 3261753
Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes.
Smeland EB, Blomhoff HK, Funderud S, Shalaby MR, Espevik T., J. Exp. Med. 170(4), 1989
PMID: 2677211
Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages.
Bauer J, Ganter U, Geiger T, Jacobshagen U, Hirano T, Matsuda T, Kishimoto T, Andus T, Acs G, Gerok W., Blood 72(4), 1988
PMID: 3262381
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts.
Bucala R, Ritchlin C, Winchester R, Cerami A., J. Exp. Med. 173(3), 1991
PMID: 1997647
Production and modulation of interleukin 6 synthesis by synoviocytes derived from patients with arthritic disease.
Rosenbaum JT, Cugnini R, Tara DC, Hefeneider S, Ansel JC., Ann. Rheum. Dis. 51(2), 1992
PMID: 1550404
Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts.
Tan PL, Farmiloe S, Yeoman S, Watson JD., J. Rheumatol. 17(12), 1990
PMID: 1707461
Interleukin-6 and the acute phase response.
Heinrich PC, Castell JV, Andus T., Biochem. J. 265(3), 1990
PMID: 1689567
Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primary cultures.
Andus T, Geiger T, Hirano T, Kishimoto T, Tran-Thi TA, Decker K, Heinrich PC., Eur. J. Biochem. 173(2), 1988
PMID: 2452086
Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes.
Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC., FEBS Lett. 242(2), 1989
PMID: 2464504
Transforming growth factor-beta enhances interleukin-6 secretion by intestinal epithelial cells.
McGee DW, Beagley KW, Aicher WK, McGhee JR., Immunology 77(1), 1992
PMID: 1398766
Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.
Cajot JF, Bamat J, Bergonzelli GE, Kruithof EK, Medcalf RL, Testuz J, Sordat B., Proc. Natl. Acad. Sci. U.S.A. 87(18), 1990
PMID: 2169614
Plasminogen activator inhibitor-1 is induced in microvascular endothelial cells by a chondrocyte-derived transforming growth factor-beta.
Pepper MS, Montesano R, Orci L, Vassalli JD., Biochem. Biophys. Res. Commun. 176(2), 1991
PMID: 2025278
Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts.
Matrisian LM, Leroy P, Ruhlmann C, Gesnel MC, Breathnach R., Mol. Cell. Biol. 6(5), 1986
PMID: 2431284
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.
Arend WP, Dayer JM., Arthritis Rheum. 33(3), 1990
PMID: 2180403
Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals.
Brandes ME, Allen JB, Ogawa Y, Wahl SM., J. Clin. Invest. 87(3), 1991
PMID: 1999490
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 8129795
PubMed | Europe PMC

Suchen in

Google Scholar